Tokyo, Aug. 11 -- UMIN Clinical Trials Registry (UMIN-CTR) received information related to the study (UMIN000062512) titled 'A cross-sectional questionnaire survey on psychiatrists' attitudes and practices regarding outpatient initiation of clozapine' on Aug. 7.
Study Type:
Observational
Primary Sponsor:
Institute - Kansai Medical University
Condition:
Condition - Treatment-resistant schizophrenia; clozapine treatment (study subjects are psychiatrists / society members)
Classification by malignancy - Others
Genomic information - NO
Objective:
Narrative objectives1 - To describe the attitudes, current practices, perceived barriers, conditions for acceptability, and unmet needs of Japanese psychiatric specialists regarding outpatient initiation of clozapine, in order to inform possible revision of the Japanese package insert. This is a descriptive cross-sectional survey without a single hypothesis-testing primary endpoint.
Basic objectives2 - Others
Eligibility:
Age-lower limit - 24
years-old
<=
Age-upper limit - Not applicable
Gender - Male and Female
Key inclusion criteria - 1) Member of JSCNP or JSNP; 2) Physician; 3) Understands the purpose of the survey and consents to respond.
Key exclusion criteria - 1) Does not meet the inclusion criteria; 2) Judged inappropriate by the principal investigator.
Target Size - 700
Recruitment Status:
Recruitment status - Preinitiation
Date of protocol fixation - 2026 Year 08 Month 06 Day
Anticipated trial start date - 2026 Year 09 Month 15 Day
Last follow-up date - 2026 Year 10 Month 31 Day
To know more, visit https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000071536
Disclaimer: Curated by HT Syndication.
